Filing Details

Accession Number:
0001209191-12-009621
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2012-02-13 18:03:45
Reporting Period:
2011-08-22
Filing Date:
2012-02-13
Accepted Time:
2012-02-13 18:03:45
Original Submission Date:
2011-08-24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347178 Vanda Pharmaceuticals Inc. VNDA Pharmaceutical Preparations (2834) 030491827
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1355537 Hristos Mihael Polymeropoulos 9605 Medical Center Drive
Suite 300
Rockville MD 20850
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-22 2,080 $5.34 400,830 No 4 P Direct
Common Stock Acquisiton 2011-08-23 7,920 $5.35 408,750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.33 to $5.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
  2. The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 382,080 shares.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.34 to $5.35, inclusive.
  4. The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 390,000 shares.